Literature DB >> 324695

Pharmacokinetics and bioavailability of sodium valproate.

U Klotz, K H Antonin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324695     DOI: 10.1002/cpt1977216736

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  36 in total

1.  Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.

Authors:  Abhishek Katiyar; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-09

2.  Acute sodium valproate intoxication: occurrence of renal failure and treatment with haemoperfusion-haemodialysis.

Authors:  A M Roodhooft; K Van Dam; D Haentjens; G A Verpooten; K J Van Acker
Journal:  Eur J Pediatr       Date:  1990-02       Impact factor: 3.183

Review 3.  Disposition of anticonvulsants in childhood.

Authors:  J I Morrow; A Richens
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 4.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

5.  Rectal administration of sodium valproate in children.

Authors:  E Scanabissi; D Dal Pozzo; E Franzoni; C Galloni; G Mengoli; R Calivà
Journal:  Ital J Neurol Sci       Date:  1984-06

6.  Disposition of sodium valproate in epileptic patients.

Authors:  E Perucca; G Gatti; G M Frigo; A Crema; S Calzetti; D Visintini
Journal:  Br J Clin Pharmacol       Date:  1978-06       Impact factor: 4.335

Review 7.  Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.

Authors:  E Yukawa
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

8.  First-dose and steady-state pharmacokinetics of valproic acid in children with seizures.

Authors:  K Hall; N Otten; J Irvine-Meek; M Leroux; D Budnick; M Verma; S S Seshia
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

9.  Impact of generic substitution of anticonvulsants on the treatment of epilepsy.

Authors:  A Richens
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

10.  Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients.

Authors:  Ehab S EL Desoky; Eliane Fuseau; Salah EL Din Amry; Valérie Cosson
Journal:  Eur J Clin Pharmacol       Date:  2003-12-12       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.